The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing’s Disease during Active Disease and 1 Year after Disease Remission
Abstract
Cardiovascular accidents represent the most important cause of death in patients with Cushing's syndrome. This prospective study aims at evaluating carotid arteries by echo-Doppler ultrasonography and clinical and metabolic markers of atherosclerosis in 25 patients with Cushing's disease (CD) before and after 1 yr of remission. Thirty-two sex- and age-matched subjects (control-1) and 32 body mass index-matched subjects (control-2) served as controls. At diagnosis, CD patients had higher body mass index, waist to hip ratio (WHR), total, low-density lipoprotein-cholesterol and total/high-density lipoprotein (HDL) ratio, glucose and insulin, as well as lower HDL-cholesterol than control-1; they had higher WHR and total/HDL ratio and lower HDL-cholesterol than control-2. They also had higher intima-media thickness (IMT), and lower systolic lumen diameter and distensibility coefficient (DC) than either control group. Atherosclerotic plaques were detected in 31.2% of patients, 0 control-1, and 6.2% of control-2 subjects. One year after remission, WHR, LDL-cholesterol, and IMT significantly decreased, whereas systolic lumen diameter and DC significantly increased. However, all of the above parameters were still abnormal compared with control-1, but not control-2. A significant correlation was found between WHR, glucose and insulin levels, and right and left carotid IMT. WHR was the best predictor of left IMT and left DC in active, but not in cured, patients. The duration of hypercortisolism was the best predictor of right DC in active but not in cured patients. In conclusion, patients with CD have severe atherosclerotic damage. The persistence of a metabolic syndrome, vascular damage, and atherosclerotic plaques after cortisol level normalization makes these subjects still at high cardiovascular risk despite disease remission.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From % to % of patients with endogenous CS have DM, and % to % have defective glucose tolerance, so the overall prevalence of glucose metabolism impairments can come close to %, as shown in Table (, , -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [183]
In the citing paper
“Controlling hypercortisolism is the first step toward improving glucose metabolism in patients with endogenous CS, but different treatments for hypercortisolism may affect the outcome of diabetes, regardless of how well cortisol excess is corrected (, , , , , , ).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [183]
In the citing paper
“Other prospective studies [Faggiano et al., (); Giordano et al., ()] reported similar findings in patients with CS before and year after remission was achieved thanks to pituitary neurosurgery, pituitary irradiation, or adrenalectomy.”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [183]
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Williams Textbook of Endocrinology
Melmed, S., & Polonsky, K. S. (2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,715
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,458
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 1×
“(28), impairment of glucose tolerance (29), and gestational diabetes (30).”
BackgroundBorch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Diabetes and Endothelial Dysfunction: A Clinical Perspective
Calles-Escandón, J., & Cipolla, M. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0417 · Cited by 657
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5896 · Cited by 450
Self-citationEndothelial dysfunction in diabetes mellitus.
Cosentino, F., & Lüscher, T. F. (1998) · PubMed · Cited by 259
Gamble, G. D., Zorn, J., Sanders, G. P., MacMahon, S. W., & Sharpe, N. (1994) · Stroke · doi:10.1161/01.str.25.1.11 · Cited by 204
Impaired Endothelium-Dependent Vasodilatation in Women With Previous Gestational Diabetes
Anastasiou, E., Lekakis, J. P., Alevizaki, M., Papamichael, C. M., Megas, J., Souvatzoglou, A., & Stamatelopoulos, S. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2111 · Cited by 188
Book Review: Obesity: A Report of the Royal College of Physicians
Yudkin, J. (1983) · Journal of the Royal Society of Medicine · doi:10.1177/014107688307600624 · Cited by 180
Hogikyan, R. V., Gałecki, A. T., Pitt, B., Halter, J. B., Greene, D. A., & Supiano, M. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4907 · Cited by 151
Westerbacka, J., Vehkavaara, S., Bergholm, R., Wilkinson, I. B., Cockcroft, J., & Yki‐Järvinen, H. (1999) · Diabetes · doi:10.2337/diabetes.48.4.821 · Cited by 151
Kario, K., Matsuo, T., Kobayashi, H., Matsuo, M., Sakata, T., & Miyata, T. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1114 · Cited by 149
Ferri, C., Desideri, G., Baldoncini, R., Bellini, C., Angelis, C. D., Mazzocchi, C., & Santucci, A. (1998) · Diabetes · doi:10.2337/diabetes.47.4.660 · Cited by 127
Markers of activation of coagulation and fibrinolysis in patients with Cushing’s syndrome
Fatti, L. M., Bottasso, B., Invitti, C., Coppola, R., Cavagnini, F., & Mannucci, P. M. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343697 · Cited by 90
Kaur, K., & Findling, J. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-103-5_3 · Cited by 71
Type 2 diabetes: one disease, multiple cardiovascular risk factors.
Calles-Escandón, J., Garcı́a-Rubi, E., Mirza, S. A., & Mortensen, A. (1999) · PubMed · Cited by 70
Ambrosi, B., Sartório, A., Pizzocaro, A., Passini, E., Bottasso, B., & Federici, A. B. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-8000 · Cited by 52
A practical approach to treatment of the obese patient
Yanovski, J. A. (1993) · Archives of Family Medicine · doi:10.1001/archfami.2.3.309 · Cited by 46
Stamler, J., Pick, R. L., & Katz, L. N. (1954) · Circulation · doi:10.1161/01.cir.10.2.237 · Cited by 41
Persistent hypertension after successful adrenal operation.
Simon, D., Goretzki, P. E., Lollert, A., & Röher, H.-D. (1993) · PubMed · Cited by 33
Enhancement of Experimental Atherosclerosis by ACTH in the Dog.
Rosenfeld, S., Marmorston, J., Sobel, H., & White, A. (1960) · Experimental Biology and Medicine · doi:10.3181/00379727-103-25420 · Cited by 30
Risk Factors Associated with Persistent Postoperative Hypertension in Cushing's Syndrome
Suzuki, T., Shibata, H., Ando, T., Kurihara, I., Kobayashi, S., Hayashi, K., Hayashi, M., Kawabe, H., Saito, I., Murai, M., et al. (2000) · Endocrine Research · doi:10.3109/07435800009048601 · Cited by 22
Insulin Resistance in Cushing's Syndrome
Karnieli, E., Cohen, P., Barzilai, N., Ish-Shalom, Z., Armoni, M., Rafaelov, R., & Barzilai, D. (1985) · Hormone and Metabolic Research · doi:10.1055/s-2007-1013593 · Cited by 17
Lorenzen, I., & Lk, H. (1967) · PubMed · Cited by 9
Reinartz, G., Angermaier, A., Buchfelder, M., Fahlbusch, R., & Georgieff, M. (1995) · Hormone and Metabolic Research · doi:10.1055/s-2007-979993 · Cited by 8
Cited by
Sorted by citations
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.189141 · Cited by 1,416
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Newell-Price, J. D. C., BERTAGNA, X. Y., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,258
Metadata
- Authors
- Faggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A.
- Affiliations
- Federico II University Hospital (IT)
- Corresponding author
- Colao, Annamaria
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2527-2533
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2107774273
- Cited by
- 358
- References
- 30
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 17 · 2021: 13 · 2020: 14 · 2019: 13 · 2018: 7 · 2017: 19 · 2016: 19 · 2015: 18 · 2014: 22 · 2013: 24 · 2012: 20
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- Cushing's disease, carotid artery stiffness, carotid intima-media thickness, atherosclerosis, cardiovascular risk factors, remission, waist-to-hip ratio, metabolic syndrome, carotid distensibility, atherosclerotic plaque, HDL cholesterol, insulin resistance
- MeSH terms
- Adult, Arteriosclerosis, Cardiovascular Diseases, Cushing Syndrome, Elasticity, Female, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Remission Induction, Risk Factors, Time Factors, Ultrasonography, Carotid Artery, Common
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
